Survivorship Care for Cancer Survivors
(CASCADE Trial)

Recruiting in Palo Alto (17 mi)

Overseen byBijal Balasubramanian, MBBS, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: The University of Texas Health Science Center, Houston

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to implement a clinic-level cancer survivorship care delivery intervention in partnership with community health center clinicians, patients, and community representatives to test effectiveness of the intervention to improve patient and clinician outcomes and to evaluate implementation of the intervention using an iterative, concurrent mixed-methods approach guided by the Practice Change Model.

Eligibility Criteria

This trial is for individuals who have survived cancer and are receiving care at community health centers. It aims to involve clinicians, patients, and community members in enhancing survivorship care.

Inclusion Criteria

Participants: at least one visit to the Community Health Centers (CHCs) in the prior year

Clinicians: employed clinicians (e.g. physicians, nurses, pharmacists, or other allied health professionals) and non-clinician staff of the participating CHC clinics

Exclusion Criteria

I have never had cancer before.

Treatment Details

Interventions

Survivorship care delivery intervention (Behavioral Intervention)

Trial OverviewThe study tests a new way of delivering care to cancer survivors at clinics. It looks at how effective this approach is in improving outcomes for both patients and doctors using mixed methods guided by the Practice Change Model.

Participant Groups

4Treatment groups

Experimental Treatment

Group I: Step 4 (2 clinics)- 24 months control then 12 months interventionExperimental Treatment1 Intervention

Group II: Step 3 (2 clinics)-18 months control then 12 months interventionExperimental Treatment1 Intervention

Group III: Step 2 (2 clinics)-12 months control then 12 months interventionExperimental Treatment1 Intervention

Group IV: Step 1 (2 clinics)-6 months control then 12 months interventionExperimental Treatment1 Intervention